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Abstract
Background: Plasmodium falciparum, one of  the causative agents of  malaria, has high adaptability through mutation and is 
resistant to many types of  anti-malarial drugs. This study presents an in vitro assessment of  the antiplasmodial activity of  
some phenolic compounds isolated from plants of  the genus Allanblackia. 
Methods: Tests were performed on well plates filled with a fixed parasitized erythrocytes volume. Compounds to be tested 
were then added in wells. After incubation, tritiated hypoxanthine is added and the plates were returned to the incubator. 
After thawing, the nucleic acids are collected. Inhibitory Concentration 50 (IC50) was determined by linear interpolation.
Results: From Allanblackia floribunda, have been isolated and characterized 1,7-dihydroxyxanthone 1, macluraxanthone 4, 
morelloflavone 9, Volkensiflavone 10 and morelloflavone 7-O-glucoside 11; from Allanblackia monticola, α-mangosine 
2, rubraxanthone 3, allaxanthone C 5, norcowanine 6 , tovophiline A 7, allaxanthone B 8 and from Allanblackia gabonensis, 
1,7-dihydroxyxanthone 1. Six of  them were evaluated for their antimalarial properties. The most active compound, maclu-
raxanthone, presented a very interesting activity, with an IC50 of  0.36 and 0.27 µg/mL with the F32 and FcM29 strains 
respectively.
Conclusion: This work confirms that species of  Allanblackia genus are medicinally important plants containing many biolog-
ically active compounds that can be used effectively as antiplasmodial. 
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Introduction
Malaria remains one of  the major pandemics and is a 
main public health problem especially in Africa1. Ma-
laria is found in tropical and sub-tropical regions of  
the southern hemisphere. More than two billions peo-
ple are at risk of  contracting this disease worldwide. A 
microscopic parasite called Plasmodium falciparum is re-
sponsible for the most dangerous form of  malaria. This 
parasite is transmitted by the female mosquito species 
belonging to the genus Anopheles2. 
Currently, despite the existing therapeutic arsenal, few 
drugs are available in the market and are not always 
accessible to the affected population. Additionally, the 
increased parasite’s resistance to current treatments re-
inforces the urgent need to search for new antimalarial 
drugs. Because of  the high cost of  the prescribed drugs 
and the various activities displayed by medicinal plants 
against many diseases, 80% of  the world population re-
lies on medicinal plants for their basic and first health-
care. Two current so-called antimalarial drugs have 
been derived from medicinal plants traditionally used in 
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their countries of  origin against fevers and malaria. This 
includes the bark of  a tree native to the slopes of  the 
Andean Cordillera (Cinchona calisaya and other species 
of  Cinchona) and a native Chinese herb Artemisia annua3. 
These findings encourage the search for new antima-
larial drugs in plant biodiversity. In Cameroon, a large 
number of  plant species have been identified as anti-
malarial medicinal plants. Pure natural products com-
pounds have been isolated from some of  these plants 
and their antimalarial activities were comparable to or 
more active than chloroquine on sensitive and resistant 
strains of  P. falciparum4. Plasmodium falciparum, one 
of  the causative agents of  malaria, has high adaptabil-
ity through mutation and is resistant to many types of  
anti-malarial drugs. This resistance is a serious setback 
to antimalarial programs since it precludes the use of  
cheap and previously effective drugs like chloroquine. 
New families of  active compounds are needed, espe-
cially from natural sources in order to decrease the risk 
of  resistance. An alternative solution in many endemic 
countries is the use of  traditional medicinal plants since 
many of  the available antimalarial drugs are from plants 
sources, and the potential of  plants to produce new an-
tiprotozoal agents are considerable.
The phytochemical and pharmacology studies of  plants 
of  the genus Allanblackia revealed the presence of  bio-
logically active secondary metabolites belonging to ben-
zophenones, xanthones, triterpenes, phytosterols and 
biflavonoids5-9. A floribunda was studied for antioxidant, 
antitumor and antimicrobial activities10, ejaculatory ac-
tivities11, antioxidative properties and hypolipidemic 
effects12, free radical scavenging activities13; A monticola 
for leishmanicidal and cholinesterase activities14, anti-in-
flammatory and anti-nociceptive activities15, anti-oxida-
tive and anti-inflammatory activities16, apoptotic and 
antiproliferative activities9 and for antiplasmodial activ-
ity17,18; A. gabonensis for antiparasitic and antimicrobial8, 
hepatho-nephroprotective and antioxidant activities19, 
analgesic and anti-inflammatory activities20.
In the present study, we report on the antiplasmodial 
activity of  isolated phenolic compounds which were 
not evaluated before as well as the crude extracts from 
some cameroonian plants of  the genus Allanblackia: A. 
floribunda, A. monticola and A. gabonensis.
 
Materials and methods 
Plant materials
Allanblackia floribunda, Allanblackia gabonensis and Allan-
blackia monticola plants belonging to the family of  Gut-
tiferaceae were collected respectively on top of  Mount 
Kala in the Central Region Cameroon for the first two 
species and Bangangté area of  Western Cameroon to 
the latter species. They were then identified by Dr. Zap-
fack from the Botany Department at the University of  
Yaounde I. Voucher specimens were deposited at the 
National Herbarium of  Cameroon.
Extraction and isolation
Plants were then cut, air-dried and powdered. The 
powders obtained were then macerated with CH2Cl2/
MeOH (1/1) at room temperature for 48 h followed 
by pure methanol for 4 hours. After evaporation under 
reduced pressure, the crude extracts were obtained8,10,16. 
The various crude extracts were submitted to  fractiona-
tion using hexane-ethyl acetate of  increasing polarity as 
eluent. Fractions of  300 mL were collected and pooled 
on the basis of  their thin layer chromatography (TLC) 
profiles. Further purification through successive col-
umn chromatography yielded several pure compounds 
belonging to many classes of  compounds. 
Identification of  compounds
The isolated compounds were then characterized us-
ing various spectroscopic and spectrometric techniques 
such as 1D- and 2D-NMR and MS. Melting points were 
determined using a Kofler bench and are uncorrected. 
The mass spectra were recorded on a API Q-STAR 
PULSAR spectrometer. The ¹H- and ¹³C-NMR spec-
tra were recorded on a Bruker 300 and 75 MHz spec-
trometer respectively with TMS as internal standard. 
Coupling constants are expressed in Hertz. NOESY, 
HMBC, HSQC and Jmod experiments were performed 
with conventional pulse sequences and on a 400 MHz 
Brucker spectrometer. Column chromatography (CC) 
and TLC were carried out on silica gel 60H Merk, 70-
230, 200-300 mesh; GGo, GF254 aluminum plates 20 x 
20 cm Merck and Analtech; respectively. Spots were vis-
ualized by UV lamp (254 nm and 365 nm) or by spray-
ing with 50% H2SO4/H2O solution, or using iodine. 
The in vitro antimalarial activity was performed on two 
reference strains of Plasmodium falciparum: the F32 strain 
from Tanzania, chloroquine-sensitive and native of-
Cameroon FcM29 strain resistant to chloroquine
21. The 
tests were performed using the radio-isotope technique 
based on the method previously described by Desjar-
dins22 and modified by Benoit23. 
 
Assays of  bio-activity
Tests were performed on 96 well plates filled with a 
fixed parasitized erythrocytes (parasitemia of  1.0% and 
1.5% hematocrit) volume. Fractions to be tested (at 
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different concentrations) were then added in triplicate 
wells. After 24 h incubation at 37°C, 0.25 µCi of  the tri-
tiated hypoxanthine is added in each well (Perkin Elmer 
1 µCi/mL, France) and the plates were returned to the 
incubator for 24 h. At the end of  the cycle, the plates 
are frozen at – 20°C to cause hemolysis of  erythrocytes. 
After thawing (4th day), the nucleic acids are collected 
onto filters using an automated cell collector (Perkin 
Elmer, France). The radioactivity on the filter (dried in 
a microwave and wrapped in plastic to which are add-
ed 4 mL of  liquid scintillation (Betaplate Scint, Perkin 
Elmer) is then measured by a β counter (Microbeta Tri-
lux, Perkin Elmer). Inhibitory Concentration 50 (IC50) 
(sample concentration which inhibits 50% of  the para-
site growth) is determined by linear interpolation, with 
the ratio of  the percentage of  parasitemia on the loga-
rithm of  the concentrations of  samples. The radioactiv-




After the characterization of  the isolated compounds, 
we identified 05 pure compounds from A. floribunda: 
1,7-dihydroxyxanthone, macluraxanthone, morello-
flavone, volkensiflavone and morelloflavone 7-O-glu-
coside10,24, 06 from A. monticola: α-mangosine, rubrax-
anthone, allaxanthone, norcowanine, tovophiline A, 
allaxanthone B7,16 and 01 from A. gabonensis, 1,7-dihy-
droxyxanthone8. The structures are showed in Table 1. 
Table 1. Chemical structure of isolated compounds from Allanblackia 
Name  Structure Source References 
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It is clear from this table that the phenolic compounds 
contained in the plants of  the genus Allanblackia are 
mainly xanthones and biflavonoids. 
Xanthones: The xanthones isolated from A. floribunda, 
are both prenylated and non-prenylated, while those of  
A. monticola have in their structure at least one prenyl or 
geranyl group. Xanthones from A. monticola have a B 
ring dioxygenated in position 6, 7 and prenyles or ger-
anyles groups are in positions 2, 4, 5 or 8. The isolated 
compound from A. gabonensis is a oxygenated xanthone. 
Biflavonoids: These groups of  compounds have main-
ly been isolated from A. floribunda and their two consti-
tutive units are different (flavanone-flavone type).
The linear regression allowed determining the IC50 of  
the tested compounds (Table 2). 
Table 2. Evaluation of in vitro antiplasmodial activity of the different compounds tested 
on P. falciparum F32 and FcM29 strains in comparison with chloroquine as reference 
(IC50 in µg/mL) 
Compounds F32/24h F32/72h FcM29/24h FcM29/72H 
IC50 IC50 IC50 IC50 
1,7-dihydroxy xanthone1 16.05 +/- 9.02 19.87 +/- 19.15 17.93 +/- 5.40 15.34 +/- 4.23 
macluraxanthone           4 0.46 +/- 0.12 0.36 +/- 0.06 0.33 +/- 0.08 0.27 +/- 0.01 
allaxanthone B             8 3.70 +/- 1.05 3.09  +/-  0.13 3.93 +/- 0.40 3.43 +/- 0.57 
morreloflavone             9 11.77 +/- 9.55 3.36 +/- 2.00 12.59 +/- 12.03 4.80 +/- 2.21 
volkensiflavone          10 0.99 +/- 0.62 1.18 +/- 1.25 0.93 +/- 0.20 0.95 +/- 0.27 
morreloflavone 7-O-
glucoside                     11 
  
11.45 +/- 14.51 
  
8.38 +/- 10.87 
  
28.92 +/- 7.45 
  
23.82 +/- 7.58 
chloroquine  0.036 0.036 0.57 0.57 
EAF 5.38 +/- 0.83 5.43 +/- 1.31 4.92 +/- 1.43 4.48 +/- 1.47 
EAG 35.38 +/- 2.87 32.01 +/- 1.21 25.17 +/- 2.87 24.30 +/- 4.04 
EAM 3.27 +/- 0.25 3.33 +/- 0.17 3.08 +/- 0.08 2.13 +/- 1.07 
EAF: Crude extract of the bark of A. floribunda, EAM: Crude extract from the bark of A. 
monticola, EAG: Crude extract fromthe bark of A. gabonensis. 
 
After 24h of  contact with the parasite, volkensiflavone 
(IC50: 0.99 µg/mL) and macluraxanthone (IC50: 0.46 
µg/mL) displayed the best activity on the F32 strain 
while chloroquine (IC50: 0.036 µg/mL) was used as ref-
erence. With FcM29 strain, volkensiflavone (IC50: 0.93
μg/mL) and macluraxanthone (IC50: 0.33 μg/mL) re-
mained the most active compounds, but the
macluraxanthone was more active than the reference 
(chloroquine: IC50: 0.57 μg/mL). After 72 h of  con-
tact, macluraxanthone (IC50: 0.36 µg/mL) exhibited 
the high activity on the F32 strain and with FcM29 strain, 
it was most active (IC50: 0.27 μg/mL). Additionally, 
several other compounds also showed good activities: 
volkensiflavone (IC50: 0.95 µg/mL) and α-mangosine 
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(IC50: 0.33 µg/mL). For the most active compounds 
(macluraxanthone), we noted that when it was allowed 
to go from 24 to 72 h of  contact with parasite, there was 
increased activity of  0.1 µg/mL with the F32 strain and 
0.06 µg/mL with FcM29 strain. Similarly, for α-man-
gosine, we got an increase in activity of  1.39 µg/mL 
with FcM29 layer. In contrast, for volkensiflavone there 
was a decrease in activity of  0.19 µg/mL with the F32 
strain and 0.02 µg/mL with FcM29 strain when going 
from 24 to 72 h of  contact with parasite. 
Discussion
From all tested compounds, macluraxanthone is the 
most active compound on two strains of  Plasmodium 
with a mean IC50 of  0.36 and 0.27 μg/mL for the F32 
and FcM29 strains respectively. Five of  those prenylated 
xanthones (α-mangosine, tovophiline A, allaxanthone 
C, rubraxanthone, norcowanine) isolated form A. mon-
ticola previously tested for antiplasmodial properties had 
displayed after 24 h of  contact with the parasite a sig-
nificant antiplasmodial activity (IC50: 1.96 - 3,16 µg/
mL) on the F32 strain and (IC50: 1.72 - 3.22 µg/mL) on 
FcM29
17,18. This activity is less interesting than that of  
macluraxanthone (IC50: 0.46 and 0.33 µg/mL respec-
tively with F32 and FcM29). We also noted that its chemi-
cal structure contains two isoprene chain groups.1,7 di-
hydroxanthone (without isoprenyl group) showed very 
low activity (16,05 μg/mL). 
It can then be suggested that the antiplasmodial activ-
ities of  these compounds could be improved by the 
presence of  isoprenyl groups on their structures. For 
comparison, four xanthones and three of  their an-
alogues have been isolated from Cratoxylum maingayi 
and Cratoxylum cochinchinense (Clusiaceae), respectively, 
and these compounds showed antiplasmodial activi-
ty against P. falciparum at concentrations of  11.0 to 1.9 
μM25, less active than macluraxanthone (0.6 μM). As 
for biflavonoids, those flavanone-flavone types are the 
most active. Volkensiflavone exhibited antiplasmodial 
activity with mean IC50 of  1.5 μM, which is a signifi-
cant value compared to those of  other biflavonoids. For 
example, four biflavonoids were isolated from Ormocar-
pum kirkii and showed antiplasmodial activity toward P. 
falciparum strain K1; isochamaejasmin was the most ac-
tive among the four with an IC50 of  7.3 μM26. For the 
three biflavonoides tested, we realize that the presence 
of  the hydroxyl group in position 3’ in the morellofla-
vone and morelloflavone 7-O-glucoside (IC50: 11.77 
and 11.45 µg/mL respectively) causes a sharp drop in 
activity compared to that of  the volkensiflavone (IC50: 
0.99 µg/mL) with the F32 strain after 24 h contact with 
the parasite, but also in general way. Moreover, it was 
reported that the activity exhibited by the crude extract 




This work confirms that species of  Allanblackia genus 
are medicinally important plants containing many bio-
logically active compounds that can be used effectively 
as antiplasmodial. The antiplasmodial activity of  these 
isolated phenolic compounds were particularly high 
and more so with isoprenylated ones. This study can 
validate at least in part the uses of  species of  Allanblack-
ia for the treatment of  febrile aches. Further studies are 
however required to establish the role played by the iso-
prenylated groups in antiplasmodial study. The isolated 
compounds tested in this investigation can also be sug-
gested as lead compounds for future development of  
economic antimalarial drugs. 
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